Carlyle-backed oil pipeline company Crescent Midstream is weighing a possible sale after drawing takeover interest, Bloomberg’s Gillian Tan reports, citing people with knowledge of the matter. The company, which could be valued at roughly $1.3B including debt, has hired an advisor to help it explore options, Tan notes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Carlyle price target raised to $60 from $58 at JMP Securities
- Carlyle price target raised to $56 from $55 at Barclays
- Carlyle weighing strategic options for StandardAero, Reuters reports
- Carlyle Group Board Evolution with Afsaneh Beschloss’s Arrival
- Teva, Launch Therapeutics enter clinical collaboration agreement